Martin Shaw, Business Development at AroCell, held a presentation on the Thymidine Kinase 1 immunoassay, highlighting its significance as a valuable translational biomarker from drug discovery through to clinical trials. You can see the presentation below.
Visit from Beckman Coulter Diagnostics focused on market development
We had the pleasure of welcoming our long-term partner Beckman Coulter Diagnostics this week for valuable discussions on the continued sales and market development for our IRMA and ELISA portfolio. Their strong market presence and ability to effectively navigate a...
